AMMAN — The World Bank (WB) approved on June 16, 2021, $63.75 million in additional financing for the ongoing Jordan COVID-19 Emergency Response project to support Jordan’s efforts to promote safe, efficient and equitable access to COVID-19 vaccines.

It will help accelerate Jordan’s progressive vaccination programme which is vital for reopening the economy, schools, and hard-hit sectors, according to a statement posted on the World Bank’s website.

With new financing, the project will support Jordan in reaching its target of vaccinating 75 per cent of its adult population, which will contribute to an early and resilient recovery.

The additional financing includes a $50 million loan from the International Bank for Reconstruction and Development (IBRD), a $12.5 million concessional amount from the Global Concessional Financing Facility (GCFF), and a $1.25 million grant from the Health Emergency Preparedness and Response Trust Fund.

“The Government of Jordan appreciates this additional financing for vaccine support which is part of the $1.1 billion in combined loans and grant financing from the World Bank and international partners recently announced to support Jordan in responding to the pandemic and promoting an early, climate-resilient, and inclusive recovery,” Minister of Planning and International Cooperation Nasser Shraideh was quoted in the statement as saying.

With concessional financing support from the GCFF, the project will provide inclusive and equitable access to COVID-19 vaccines for Syrian refugees, the statement said.

Jordan is one of the first countries in the world to include refugees as vaccine beneficiaries per the National Deployment and Vaccination Guide for COVID-19. In addition, with financial support from the HEPRTF, the project will strengthen COVID-19 case management for Syrian refugees.

“The government has accelerated its efforts and set ambitious vaccination targets for a phased and safe reopening,” Health Minister Feras Hawari was quoted in the statement as saying.

“World Bank financing support will help us meet these goals,” he said.

“Equitable, broad, and fast access to COVID-19 vaccines is critical to protecting lives and provides the foundation for economic recovery," Saroj Kumar Jha, Mashreq Regional Director, World Bank Group, said in the statement.

"This additional financing will support Jordan in expanding its inclusive and efficient vaccination program,” he added.

Jordan remains highly vulnerable to COVID-19. By mid-June 2021, there have been over 739,000 confirmed cumulative cases, with more than 9,500 confirmed deaths, according to the statement.

Jordan started its COVID-19 vaccination campaign in January 13, 2021. More than 2 million adults were vaccinated with the first dose, while over 800,000 adults are fully vaccinated, 33 per cent and 13 per cent of the eligible adult population, respectively, the statement said.

The additional financing seeks to enable the critically needed acquisition of vaccines from a range of sources to support Jordan’s objective to have a portfolio of options to access vaccines under the right conditions (value-for-money, regulatory approvals, and delivery time among other key features).

Since the start of the COVID-19 pandemic, the World Bank Group has committed over $125 billion to fight the health, economic, and social impacts of the pandemic, the fastest and largest crisis response in its history, the statement said.

The financing is helping more than 100 countries strengthen pandemic preparedness, protect the poor and jobs, and jump start a climate-friendly recovery. The bank is also providing $12 billion to help low- and middle-income countries purchase and distribute COVID-19 vaccines, tests, and treatments, concluded the statement.

© Copyright The Jordan Times. All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.